Newsletter | April 13, 2026

04.13.26 -- Immobilized Enzymes Promise Alternative To Cyanogen Bromide's Toxicity

SPONSOR

Biopharma innovation is accelerating. Can supply chains and talent pipelines keep up?

According to our Global Biopharma Index 26% of executives say supply chains aren’t equipped to support advanced modalities. 38% report critical workforce shortages to support fast growing areas like cell and gene therapy, antibody-drug conjugates, and mRNA. Now is the time for all industry players to think outside the box and take action to ensure biopharma delivers on its promise. Explore the full report.

FOCUS ON UPSTREAM MANUFACTURING

Immobilized Enzymes Promise Alternative To Cyanogen Bromide's Toxicity

Proteases may be more expensive up front, but the benefits of cutting out a highly toxic substance quickly add up when disposal and environmental safety costs go down.

5 Best Practices To Keep Your Incubator Shaker Contamination-Free

Learn five essential best practices to maintain a sterile incubator shaker environment, from routine cleaning and humidity control to advanced HEPA filtration for reliable results.

An Alternative Genetic Engineering Tool In CHO Cells

Discover how transposon technology is being reimagined as a genetic engineering tool to create high-performing CHO cell lines for biotherapeutic production with enhanced metabolic and glycan profiles.

Advanced Approaches For Developing And Optimizing Perfusion Platforms

Examine how to effectively use small-scale perfusion-mimic systems to identify optimal cell culture media and significantly increase volumetric productivity for large-scale biomanufacturing.

Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies

Explore a streamlined approach to transient AAV production, including yield improvements across serotypes, key transfection parameters, and practical guidance for scaling processes.

Manufacturing Of "MSC 2.0" Using Functionally Closed Systems

Transitioning to closed systems enables the 100-fold expansion of engineered cells. Achieve high yields and maintain anti-cancer potency while reducing contamination risks and labor.

Lipid Nanoparticles Boost CRISPR HDR Gene Insertion In Human T Cells

Lipid nanoparticles enable precise, non-viral gene editing in T cells to achieve high HDR efficiency and viability in scalable workflows. See how this approach overcomes viral vector limitations.

Unlocking ROI And Capacity In Monoclonal Antibody Manufacturing

Perfusion-based upstream production offers up to 24% lower cost and significantly higher productivity than fed-batch, enabling faster timelines, better facility utilization, and improved quality.

Understanding And Mitigating Oxygen Heterogeneity In Bioreactors

Oxygen heterogeneity, caused by pressure variations and other factors in large-scale bioreactors, can significantly impact cell growth and product yield.

The Advantages Of Single-Use Bioreactors

Reduce the time and risks involved in maintaining a traditional bioreactor with this single-use solution for biopharmaceutical manufacturers.

UPSTREAM MANUFACTURING SOLUTIONS

Zero Time To Master - Nordson MEDICAL

A Seismic Shift In Media And Buffer Consumption - Nucleus Biologics

Powerful And Comprehensive Cell Culture Profiling - Roche CustomBiotech

Next Generation Cell Expansion System - Terumo BCT

SPONSOR

Webinar: Reliable and comprehensive control in bioprocessing: Substrate, metabolite and product analysis at one device

Optimize bioprocess performance with Roche Cedex Analyzers. This webinar explores fast, reliable monitoring of 30+ critical culture parameters to improve yield, quality, and process control across mammalian and microbial workflows. Learn how Cedex supports everything from small-scale development to large-scale biomanufacturing with flexible testing, automation-ready integration, and smarter process optimization insights. Click here to learn more.

Connect With Bioprocess Online: